Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGET

S. Negrier, E. Jäger, C. Porta, D. McDermott, M. Moore, J. Bellmunt, S. Anderson, F. Cihon, J. Lewis, B. Escudier, R. Bukowski

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGET'. Together they form a unique fingerprint.

Medicine & Life Sciences